Alnylam Pharmaceuticals, Inc.
David E I Pyott (Director) reports ALNY insider transactions
AI-generated summary
Director David E I Pyott acquired 3,780 shares of Common Stock at an average price of $71.99 for a total value of $272,122.20 by exercising or converting derivatives on November 10, 2026. Following this transaction, the insider directly held 5,362 shares.
Key facts
- Insider
- David E I Pyott · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +3,780 | $71.99 | $272,122.20 | 5,362 | Direct |
| Nov 10, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1 | −3,780 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 The options exercised and held by the reporting person were due to expire on June 1, 2027.
- F2 The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
More ALNY filings
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- SC 13G/A
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- SC 13G
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.